UMB(US:UMBF)2020-10-29 13:02Part I Financial Statements (Unaudited) Unaudited financial statements reflect significant asset growth, increased Q3 net income, and higher credit loss provisions due to CECL adoption Consolidated Balance Sheets Total assets grew to $30.3 billion by September 30, 2020, fueled by loan and securities growth, with deposits reaching $24.7 billion Consolidated Balance Sheet Highlights (in thousands) | Account | Sep 30, 2020 (thousands) | Dec 31, 2019 (thousands) | Change ($ thousands) | Change (%) | | :--- | :--- | :--- | :--- | :--- | | Total Assets | $30,250,972 | $26,561,355 | $3,689,617 | 13.9% | | Net Loans | $15,738,489 | $13,329,934 | $2,408,555 | 18.1% | | Total Securities | $9,995,895 | $8,717,502 | $1,278,393 | 14.7% | | Total Liabilities | $27,396,792 | $23,954,915 | $3,441,877 | 14.4% | | Total Deposits | $24,737,907 | $21,603,244 | $3,134,663 | 14.5% | | Total Shareholders' Equity | $2,854,180 | $2,606,440 | $247,740 | 9.5% | Consolidated Statements of Income Net income for Q3 2020 increased to $73.1 million, driven by higher net interest income, but nine-month net income decreased due to increased credit loss provisions Q3 2020 vs Q3 2019 Performance (in thousands, except EPS) | Metric | Q3 2020 | Q3 2019 | Change (%) | | :--- | :--- | :--- | :--- | | Net Interest Income | $184,384 | $168,260 | 9.6% | | Provision for Credit Losses | $16,000 | $7,500 | 113.3% | | Noninterest Income | $112,996 | $103,635 | 9.0% | | Net Income | $73,092 | $62,382 | 17.2% | | Diluted EPS | $1.52 | $1.27 | 19.7% | Nine Months 2020 vs 2019 Performance (in thousands, except EPS) | Metric | Nine Months 2020 | Nine Months 2019 | Change (%) | | :--- | :--- | :--- | :--- | | Net Interest Income | $536,554 | $498,542 | 7.6% | | Provision for Credit Losses | $125,500 | $30,850 | 306.8% | | Noninterest Income | $331,876 | $316,415 | 4.9% | | Net Income | $130,182 | $177,085 | -26.5% | | Diluted EPS | $2.69 | $3.61 | -25.5% | Consolidated Statements of Comprehensive Income Q3 2020 comprehensive income decreased to $87.9 million due to lower OCI, while nine-month comprehensive income also declined to $346.1 million Comprehensive Income Summary (in thousands) | Component | Three Months Ended Sep 30, 2020 | Three Months Ended Sep 30, 2019 | Nine Months Ended Sep 30, 2020 | Nine Months Ended Sep 30, 2019 | | :--- | :--- | :--- | :--- | :--- | | Net Income | $73,092 | $62,382 | $130,182 | $177,085 | | Other Comprehensive Income | $14,841 | $33,404 | $215,923 | $191,803 | | Comprehensive Income | $87,933 | $95,786 | $346,105 | $368,888 | Consolidated Statements of Changes in Shareholders' Equity Shareholders' equity increased to $2.85 billion by September 30, 2020, driven by net income and OCI, partially offset by dividends and share repurchases - Key drivers for the increase in shareholders' equity during the first nine months of 2020 were net income of $130.2 million and a significant increase in accumulated other comprehensive income of $215.9 million17 - Shareholder returns included $45.2 million in cash dividends. The company also repurchased $59.6 million of its stock during the nine-month period17 - The adoption of ASU No. 2016-13 (CECL) resulted in a $7.0 million reduction to retained earnings as a cumulative effect adjustment on January 1, 202017 Consolidated Statements of Cash Flows Operating activities provided $215.6 million in cash, investing activities used $3.14 billion, and financing activities provided $3.28 billion, resulting in a $350.1 million cash increase Cash Flow Summary for Nine Months Ended Sep 30 (in thousands) | Activity | 2020 | 2019 | | :--- | :--- | :--- | | Net Cash from Operating Activities | $215,633 | $190,510 | | Net Cash from Investing Activities | ($3,143,895) | ($1,326,901) | | Net Cash from Financing Activities | $3,278,330 | $255,228 | | Net Increase (Decrease) in Cash | $350,068 | ($881,163) | Notes to Consolidated Financial Statements Notes detail accounting policies, including CECL adoption, loan portfolio, credit quality, COVID-19 loan modifications, and a significant subsequent equity investment gain - The company adopted the CECL standard on January 1, 2020, resulting in a $9.0 million increase to the allowance for credit losses and a $7.0 million reduction to retained earnings36 - As of September 30, 2020, the company had 980 remaining COVID-19 related loan modifications with a total balance of $707.1 million, primarily in the form of payment deferrals330331 - Subsequent to the quarter end, on October 15, 2020, the company recognized a significant gain from its ownership interest in Ittella International, Inc (renamed Tattooed Chef, Inc) following a business combination208 Management's Discussion and Analysis of Financial Condition and Results of Operations Management discusses COVID-19 impacts, including CECL and PPP, with Q3 2020 net income rising due to strong revenue growth, despite increased credit loss provisions, maintaining strong capital Overview The company's 2020 performance was shaped by COVID-19, leading to customer support via PPP and loan modifications, while focusing on strategic objectives like efficiency, net interest income growth, and capital management - The company is actively managing the impacts of the COVID-19 pandemic, including building the allowance for credit losses under the new CECL standard and incurring $1.4 million in nonrecurring COVID-19 specific expenses in Q3 2020218 - UMB has provided significant customer support, including originating over 5,000 PPP loans totaling $1.5 billion and offering payment deferrals and other loan modifications219 - The company's four strategic objectives are: continuously improving operating efficiencies, increasing net interest income, growing noninterest revenue, and effective capital management222223225226 Earnings Summary Q3 2020 net income increased 17.2% to $73.1 million, driven by higher net interest and noninterest income, despite increased credit loss provisions, with strong returns on assets and equity Q3 2020 Key Performance Metrics | Metric | Q3 2020 | Q3 2019 | | :--- | :--- | :--- | | Net Income | $73.1 million | $62.4 million | | Diluted EPS | $1.52 | $1.27 | | Return on Average Assets | 0.99% | 1.03% | | Return on Average Equity | 10.23% | 9.69% | Net Interest Income Q3 2020 net interest income increased 9.6% to $190.5 million due to higher earning assets, including PPP loans, despite a 36 basis point compression in net interest margin Net Interest Income and Margin Analysis (Q3 2020 vs Q3 2019) | Metric | Q3 2020 | Q3 2019 | Change | | :--- | :--- | :--- | :--- | | Net Interest Income (tax-equivalent) | $190.5M | $174.4M | +$16.1M | | Average Earning Assets | $27.8B | $22.4B | +$5.4B | | Net Interest Spread | 2.63% | 2.64% | -1 bps | | Net Interest Margin (tax-equivalent) | 2.73% | 3.09% | -36 bps | - The increase in net interest income was primarily due to favorable volume variance on loans and securities, which offset unfavorable rate variances on earning assets235242 Provision and Allowance for Credit Losses Provision for credit losses significantly increased to $16.0 million in Q3 2020 and $125.5 million for nine months, reflecting CECL and COVID-19 impacts, raising the allowance to 1.33% of loans Provision and Allowance for Credit Losses (in millions) | Metric | Q3 2020 | Q3 2019 | Nine Months 2020 | Nine Months 2019 | | :--- | :--- | :--- | :--- | :--- | | Provision for Credit Losses | $16.0 | $7.5 | $125.5 | $30.9 | | Net Charge-offs | N/A | N/A | $18.3 | $27.1 | - The allowance for credit losses on loans to total loans ratio increased to 1.33% as of September 30, 2020, compared to 0.76% at year-end 2019254 Noninterest Income Q3 2020 noninterest income increased 9.0% to $113.0 million, primarily driven by higher trust and securities processing fees, trading and investment banking fees, and other income Noninterest Income Breakdown (Q3 2020 vs Q3 2019, in thousands) | Category | Q3 2020 | Q3 2019 | Change ($) | | :--- | :--- | :--- | :--- | | Trust and securities processing | $50,552 | $45,218 | $5,334 | | Trading and investment banking | $8,678 | $5,712 | $2,966 | | Brokerage fees | $4,819 | $8,102 | ($3,283) | | Bankcard fees | $15,295 | $16,895 | ($1,600) | | Other | $13,432 | $3,711 | $9,721 | | Total Noninterest Income | $112,996 | $103,635 | $9,361 | Noninterest Expense Q3 2020 noninterest expense increased 3.4% to $198.0 million, primarily due to higher salaries and employee benefits, partially offset by decreases in marketing, legal, and other expenses Noninterest Expense Breakdown (Q3 2020 vs Q3 2019, in thousands) | Category | Q3 2020 | Q3 2019 | Change ($) | | :--- | :--- | :--- | :--- | | Salaries and employee benefits | $124,194 | $110,153 | $14,041 | | Marketing and business development | $3,038 | $5,655 | ($2,617) | | Legal and consulting | $7,244 | $8,374 | ($1,130) | | Other | $5,603 | $8,593 | ($2,990) | | Total Noninterest Expense | $197,995 | $191,397 | $6,598 | - Q3 2020 expenses included $1.4 million of non-recurring COVID-19 costs and an increase of $2.7 million in severance expenses compared to Q3 2019267 Strategic Lines of Business For nine months, Commercial Banking net income decreased to $86.6 million, Institutional Banking saw a slight decrease to $52.7 million, and Personal Banking recorded a $9.1 million net loss Net Income by Business Segment (Nine Months Ended Sep 30, in thousands) | Segment | 2020 | 2019 | Change ($) | | :--- | :--- | :--- | :--- | | Commercial Banking | $86,605 | $120,333 | ($33,728) | | Institutional Banking | $52,698 | $55,478 | ($2,780) | | Personal Banking | ($9,121) | $1,274 | ($10,395) | - In Q1 2020, the Healthcare Services segment was merged into the Institutional Banking segment to better reflect management's evaluation of the business; prior period results have been reclassified for comparability274 Balance Sheet Analysis Total assets grew 13.9% to $30.3 billion by September 30, 2020, driven by a $2.5 billion increase in loans (including PPP) and a $1.3 billion rise in securities, with deposits increasing $3.1 billion - Total assets increased by $3.7 billion since December 31, 2019, driven by a $2.5 billion increase in loans and a $1.3 billion increase in AFS securities280 - The increase in commercial and industrial loans is primarily related to the Company's participation in the PPP, with PPP loans totaling $1.5 billion as of September 30, 2020284 - In September 2020, the Company issued $200.0 million in subordinated notes to be used for general corporate purposes, including contributing capital to the Bank293 Capital and Liquidity The company maintains strong capital and liquidity, with shareholders' equity at $2.9 billion and all regulatory capital ratios well above minimums, supported by share repurchases and dividends Regulatory Capital Ratios as of September 30, 2020 | Ratio | Sep 30, 2020 | Sep 30, 2019 | | :--- | :--- | :--- | | Common equity tier 1 capital ratio | 11.93% | 12.53% | | Tier 1 risk-based capital ratio | 11.93% | 12.53% | | Total risk-based capital ratio | 14.17% | 13.51% | | Leverage ratio | 8.19% | 9.62% | - The company repurchased 1,140,399 shares of common stock during the first nine months of 2020, including 653,498 shares under an Accelerated Share Repurchase (ASR) agreement298 - The Board of Directors declared a quarterly cash dividend of $0.32 per share, an increase from the $0.31 paid in the prior quarter29917 Quantitative and Qualitative Disclosures About Market Risk The company manages interest rate risk, showing asset sensitivity, with NII projected to increase in rising rates, while credit risk is managed with nonperforming loans at $93.7 million and $707.1 million in COVID-19 loan modifications Interest Rate Risk The company manages interest rate risk, with its balance sheet slightly asset sensitive as of September 30, 2020, projecting NII increases in rising rate scenarios and decreases in falling rate scenarios Net Interest Income Sensitivity (Rate Shock Scenario, % Change) | Change in Basis Points | Year One (as of Sep 30, 2020) | Year Two (as of Sep 30, 2020) | | :--- | :--- | :--- | | +300 | 4.0% | 16.0% | | +200 | 2.7% | 11.5% | | +100 | 1.2% | 6.3% | | -100 | (3.7)% | (6.4)% | Credit Risk Management Credit risk is managed with nonperforming loans increasing to $93.7 million by September 30, 2020, representing 0.59% of total loans, and $707.1 million in COVID-19 related loan modifications outstanding Loan Quality Summary (in thousands) | Metric | Sep 30, 2020 | Dec 31, 2019 | | :--- | :--- | :--- | | Total nonperforming loans | $93,695 | $56,347 | | Total nonperforming assets | $99,373 | $59,282 | | Nonperforming loans as a % of loans | 0.59% | 0.42% | | Allowance for credit losses on loans as a % of loans | 1.33% | 0.76% | COVID-19 Loan Modifications as of Sep 30, 2020 (in thousands) | Loan Type | Balance | | :--- | :--- | | Commercial and industrial | $197,325 | | Commercial real estate | $476,631 | | Consumer real estate | $20,410 | | Total | $707,054 | Controls and Procedures Management concluded that disclosure controls and procedures were effective as of September 30, 2020, with no material changes to internal control over financial reporting during the quarter - The CEO and CFO concluded that the company's disclosure controls and procedures were effective as of the end of the quarter345 - No changes occurred during the quarter that materially affected, or are reasonably likely to materially affect, the company's internal control over financial reporting346 Part II Legal Proceedings The company is involved in various legal proceedings, none of which are expected to have a materially adverse effect on its financial condition or results of operations - In the opinion of management, none of the ongoing lawsuits are expected to have a materially adverse effect on the company's financial position, results of operations, or cash flows348 Risk Factors No material changes to the company's risk factors were reported for the quarter, consistent with prior disclosures - No material changes to risk factors were reported for the quarter349 Unregistered Sales of Equity Securities and Use of Proceeds During Q3 2020, the company repurchased 2,262 shares of common stock at an average price of $46.91, with 1.88 million shares remaining under the repurchase authorization Issuer Purchase of Equity Securities (Q3 2020) | Period | Total Shares Purchased | Average Price Paid per Share | | :--- | :--- | :--- | | July 2020 | 2,186 | $46.82 | | August 2020 | 0 | N/A | | September 2020 | 76 | $49.51 | | Total | 2,262 | $46.91 | - As of September 30, 2020, approximately 1.88 million shares may yet be purchased under the current repurchase authorization which terminates on April 27, 2021352 Exhibits This section lists exhibits filed with the Form 10-Q, including corporate documents, indenture agreements, CEO/CFO certifications, and XBRL data files